Monitoring hearing loss in cancer patients receiving chemotherapy
Official title: Research Career Scientist
Funded at Portland VA Medical Center · NIH-11020979 · Data updated 2026-11-12
This study is looking at how chemotherapy with platinum drugs might affect hearing in adults who have survived cancer, so doctors can spot any early signs of hearing loss and help patients get the support they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Portland VA Medical Center NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project start | January 1, 2024 |
| Project end | December 31, 2028 |
| Funding year | 2025 |
| NIH project number | 5IK6RX005044-02 |
| Project ID | NIH-11020979 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adult cancer patients undergoing platinum-based chemotherapy who are at risk for hearing loss.
✕Less likely to help
Patients who are not receiving platinum-based chemotherapy or those without a history of hearing issues may not benefit from this research.
What this research studies
This research focuses on the effects of platinum-based chemotherapy on hearing loss in adult cancer survivors. It aims to monitor patients for early signs of ototoxicity, which can lead to significant health and psychosocial issues. By identifying these signs early, oncologists can adjust treatment plans and audiologists can provide timely rehabilitation. The study also seeks to develop tools to predict individual susceptibility to hearing loss and tinnitus, addressing barriers to integrating audiology services into cancer care.
Why it matters
Potential benefit: If successful, this research could lead to improved management of hearing loss in cancer survivors, enhancing their quality of life.
How similar studies have gone: Previous research has shown that early monitoring and intervention can effectively mitigate the adverse effects of ototoxicity in similar patient populations.
Where this research is happening
-
Portland VA Medical Center
Portland, United States Active
Researchers
- Principal investigator: Konrad-Martin, Dawn L — Portland VA Medical Center
- Study coordinator: Konrad-Martin, Dawn L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.